Tigermed IPO Initiation: Trade-Offs
Hangzhou Tigermed Consulting (300347 CH) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
614 Views
Trade Idea Update/HK Connect Weekly: Inclusion Effective Today, XD +10%
In this insight, we will provide an update on the inclusion news today and recap on the basket performance of stocks that are included into the...
433 Views
Hepalink Pharma IPO Initiation: Take a Chance on Me
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH) is a leading China-based pharmaceutical company with global businesses in pharmaceutical, innovative...
869 Views
Trade Idea (Update): What's Next After HSCI Review Announcement
After the market close on Feb 21st, Friday, Hang Seng announced the results of the index review for the 4Q2019. In our previous note (link here),...
479 Views
Trade Idea: Buy the Candidates Of HSCI Review and HK Connect
We expect Hang Seng to announce the half-year review on Friday, Feb 21st, which will provide a list of stocks to be eligible for the inclusion into...
592 Views